DECISION OF THE EEA JOINT COMMITTEE No 256/2023

of 27 October 2023

amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1096]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Regulation (EU) 2023/127 of 18 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl in or on certain products ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Regulation (EU) 2023/128 of 18 January 2023 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benalaxyl, bromoxynil, chlorsulfuron, epoxiconazole and fenamiphos in or on certain products ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Regulation (EU) 2023/129 of 18 January 2023 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, prosulfocarb, sedaxane and valifenalate in or on certain products ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Regulation (EU) 2023/147 of 20 January 2023 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyromazine, topramezone and triflumizole in or on certain products ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Regulation (EU) 2023/163 of 18 January 2023 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for DDT and oxathiapiprolin in or on certain products ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Regulation (EU) 2023/173 of 26 January 2023 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (PAM), cycloxydim, cyflumetofen, cyfluthrin, metobromuron and penthiopyrad in or on certain products ( 6 ) is to be incorporated into the EEA Agreement.

(7) This Decision concerns legislation regarding feedingstuffs and foodstuffs. Legislation regarding feedingstuffs and foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I and the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.

(8) Annexes I and II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indents are added in point 40 (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter II of Annex I to the EEA Agreement:

‘ —

32023 R 0127 : Commission Regulation (EU) 2023/127 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 8 ),

— 32023 R 0128 : Commission Regulation (EU) 2023/128 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 22 ),

— 32023 R 0129 : Commission Regulation (EU) 2023/129 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 56 ),

— 32023 R 0147 : Commission Regulation (EU) 2023/147 of 20 January 2023 ( OJ L 20, 23.1.2023, p. 1 ),

— 32023 R 0163 : Commission Regulation (EU) 2023/163 of 18 January 2023 ( OJ L 23, 25.1.2023, p. 1 ),

— 32023 R 0173 : Commission Regulation (EU) 2023/173 of 26 January 2023 ( OJ L 25, 27.1.2023, p. 1 ).’

Article 2

The following indents are added in point 54zzy (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter XII of Annex II to the EEA Agreement:

‘ —

32023 R 0127 : Commission Regulation (EU) 2023/127 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 8 ),

— 32023 R 0128 : Commission Regulation (EU) 2023/128 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 22 ),

— 32023 R 0129 : Commission Regulation (EU) 2023/129 of 18 January 2023 ( OJ L 17, 19.1.2023, p. 56 ),

— 32023 R 0147 : Commission Regulation (EU) 2023/147 of 20 January 2023 ( OJ L 20, 23.1.2023, p. 1 ),

— 32023 R 0163 : Commission Regulation (EU) 2023/163 of 18 January 2023 ( OJ L 23, 25.1.2023, p. 1 ),

— 32023 R 0173 : Commission Regulation (EU) 2023/173 of 26 January 2023 ( OJ L 25, 27.1.2023, p. 1 ).’

Article 3

The texts of Regulations (EU) 2023/127, (EU) 2023/128, (EU) 2023/129, (EU) 2023/147, (EU) 2023/163 and (EU) 2023/173 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 4

This Decision shall enter into force on 28 October 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 5

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 27 October 2023.

For the EEA Joint Committee

The President

Pascal SCHAFHAUSER

( 1 ) OJ L 17, 19.1.2023, p. 8 .

( 2 ) OJ L 17, 19.1.2023, p. 22 .

( 3 ) OJ L 17, 19.1.2023, p. 56 .

( 4 ) OJ L 20, 23.1.2023, p. 1 .

( 5 ) OJ L 23, 25.1.2023, p. 1 .

( 6 ) OJ L 25, 27.1.2023, p. 1 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1096/oj

ISSN 1977-0677 (electronic edition)